Surbhi Saini

Profile picture
Assistant Professor of Pediatrics, Hematology and Oncology
Hematology and Oncology

phone: (314) 454-6018

Clinical Interests

Hemostatic (bleeding) and thrombotic (clotting) disorders in children


  • MBBS, Government Medical College and Hospital2006


  • Resident, Children's Hospital of Michigan/Wayne State University2008 - 2011
  • Fellow, Children’s National Health System/George Washington University School of Medicine & Health Sciences2011 - 2014
  • Fellow, Pediatric Hemostasis and Thrombosis, Nationwide Children's Hospital/Ohio State University2016 - 2017

Licensure and Board Certification

  • 2011American Board of Pediatrics, General Pediatrics
  • 2015American Board of Pediatrics, Pediatric Hematology/Oncology
  • 2016 - 2021CA, Medical Physician & Surgeon
  • 2017 - 2020PA, Medical Physician & Surgeon
  • 2019 - PresMO, Medical Physician & Surgeon

Honors and Awards

  • Darshi Gupta Memorial Prize - Final Professional Part (II) M.B.B.S examination (Pediatrics)2005
  • Dr.Devinder Sarup Singh Memorial Gold Medal - Final Professional Part (II) M.B.B.S examination2005
  • Dr.Surinder Vadehra Memorial Gold Medal - Final Professional Part (II) M.B.B.S examination2005
  • Panjab University Gold Medal - Final Professional Part (II) M.B.B.S Examination2005
  • Panjab University Gold Medal - Final Professional Part (II) M.B.B.S Examination (General Surgery)2005
  • Panjab University Silver Medal - Final Professional Part (II) M.B.B.S Examination (Internal Medicine)2005
  • Scholarship recipient, 2012 Annual Southeastern Fellows Research Skills Retreat, Duck, North Carolina2012
  • Scholarship recipient, Annual Meeting of the Mid-Atlantic Region III Federally Funded Hemophilia Treatment Centers, Alexandria, Virginia2012 - 2013
  • Certificate of Appreciation for Excellence in Teaching, Pediatric Medical Student Education Curriculum 2013-2014, George Washington University School of Medicine and Health Sciences2014
  • Scholarship recipient, Center for Advanced Training in Hemophilia and Inhibitor Management, Columbus, Ohio2016
  • Scholarship recipient, Haemophilia Academy, Edinburgh, UK2016
  • Abstract Achievement Award, American Society of Hematology, 60th Annual Meeting and Exposition, Atlanta, Georgia2017

Recent Publications view all (13)

  1. Subhyaloid hemorrhage in Evans Syndrome. Retin Cases Brief Rep. 2021. PMID:34352833 
  2. Unfractionated heparin using actual body weight without dose capping in obese pediatric patients-Subgroup analysis from an observational cohort study. Pediatr Blood Cancer. 2021;68(3):e28872. PMID:33403793 
  3. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019;209:212-219.e1. PMID:30961988 
  4. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019;33(3):425-438. PMID:31030811 
  5. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2019;32(3):305-311. PMID:30731217 
  6. Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation. J Pediatr. 2019;207:226-232.e1. PMCID:PMC6556226  PMID:30528572 
  7. Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B. Haemophilia. 2019;25(2):e126-e129. PMID:30817051 
  8. Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene. PLoS One. 2015;10(7):e0132433. PMCID:PMC4503767  PMID:26176629 
  9. Unruptured intracranial aneurysms in children with sickle cell disease: analysis of 18 aneurysms in 5 patients. Neurosurgery. 2015;76(5):531-8; discussion 538-9; quiz 539. PMID:25710108 
  10. Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder. Pediatr Blood Cancer. 2015;62(5):901-4. PMID:25307772 
  11. Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B Haemophilia . 2014;21(2):210-218. PMID:25470321 
  12. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder. J Pediatr Hematol Oncol. 2011;33(4):e156-9. PMID:21516014 
  13. Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B. Haemophilia. 2015 Mar(21(2)):210-8. PMID:25470321 
Last updated: 10/12/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130